TABLE 6-1 Cancer

Reference

Study Design

Population

Outcomes

Results

Adjustments

Comments

All cancers

CDC 1988b

Retrospective cohort, prevalence, population-based, telephone interview followed by screening medical examination

2490 Vietnam-theater veterans, 1972 Vietnam-era veterans randomly selected from 7924 theater veterans and 7364 era veterans who had entered Army in 1965-1971

Cancer (unspecified) diagnosed with medical examination

OR 1.4, 95% CI includes 1.0, NS

Age at enlistment, race, year of enlistment, enlistment status (volunteer vs draftee), score on general technical test, primary military occupational specialty

Low participation rate in control group, CI not given

VES

SCCSG 1990a

Case-control

1157 male Vietnam-theater veterans with NHL, 1776 Vietnam-era controls frequency-matched by age

Cancer diagnoses from eight city orstate cancer registries

NHL OR 1.52, 95% CI 1.00-2.32

Registry, age group in 1968, ethnicity, education, other covariates, including reported exposures to pesticides, reported medical history anddrugs, smoking, marital status, being raised Jewish

Possible exposure to Agent Orange considered although dioxin in blood not measured

SCCSG 1990b

Case-control

342 male Vietnam-theater veterans with soft-tissue or other sarcomas, 1776 Vietnam-era controls frequency-matched by age

Cancer diagnoses from eight city orstate cancer registries

Soft-tissue or other sarcomas OR 0.74, 95% CI 0.39-1.41, NS

Registry, age group in 1968, ethnicity, education, other covariates, including reported exposures to pesticides, reported medical history anddrugs, smoking, marital status, being raised Jewish

Limited power to detect rare out come



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement